Nalaganje...
Bevacizumab in metastatic breast cancer: when may it be used?
Tumor angiogenesis, which is necessary for breast cancer growth, invasion and metastases, is regulated by pro-angiogenic factors such as vascular endothelial growth factor (VEGF). Bevacizumab is a recombinant humanized monoclonal antibody that targets VEGF. The addition of bevacizumab to chemotherap...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publishing
2011-03-01
|
| Serija: | Therapeutic Advances in Medical Oncology |
| Online dostop: | https://doi.org/10.1177/1758834010397627 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|